Flexus Biosciences
Immuno-oncology biotechnology company focused on developing small molecule inhibitors of IDO1 for cancer treatment. Acquired by Bristol-Myers Squibb in 2015 for $1.25 billion.
Location
San Carlos, California, USA
Founded
2013
Investors
1
Categories
biotech, therapeutics, immuno-oncology, acquired
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Kleiner Perkins | Menlo Park, California, USA | generalist | seedseries-a+3 | 4 |